In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...

It will fund clinical trials of vaccines, which are therapeutic and often experimental, that activate the immune system to attack tumors.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.

Paul Conyngham claims he used AI tools like ChatGPT and AlphaFold to create custom mRNA vaccines that helped cure his dog’s cancer after traditional treatments failed to stop the tumour.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

The body of evidence that mRNA vaccines can transform how researchers harness the immune system to treat cancer is growing. However, even the most promising medical advances can only improve health if ...